Romcef T 1000mg/125mg Injection
Marketer
Biovensia Pharmaceutical
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Romcef T 1000mg/125mg Injection
Cefuroxime and Sulbactam injection (1000mg/125mg) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits bacterial proliferation, thus curbing infection spread. This medication must be administered solely under a physician's guidance. Consistent adherence to the prescribed dosage schedule is crucial; completing the full course of treatment is essential, even with symptom improvement. Premature cessation can compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Any worsening of these or other adverse reactions necessitates immediate medical attention. Allergic responses (such as rash, pruritus, edema, or dyspnea) require prompt medical help. Inform your doctor about all current medications before commencing treatment. Consult your physician before use during pregnancy or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a balanced diet, and sufficient hydration contribute to faster recovery. Your doctor may order lab tests to monitor the medication's efficacy.
Primary Ingredients of Romcef T 1000mg/125mg Injection
No text was provided to rewrite.
Uses of Romcef T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Romcef T 1000mg/125mg Injection:
This medication will be administered by your physician or their nursing staff; self-medication is strongly discouraged.
Common Side effects of Romcef T 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Romcef T 1000mg/125mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Romcef T 1000mg/125mg Injection works:
Ceftriaxone/Tazobactam (Romcef T 1000mg/125mg Injection) unites a cephalosporin antibiotic, Ceftriaxone, with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Tazobactam counteracts bacterial resistance mechanisms, thus augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Romcef T 1000mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
Cefuroxime (Romcef T 1000mg/125mg Injection) is typically deemed safe for use in pregnancy. Preclinical trials in animals have revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Cefuroxime axetil injection (1000mg/125mg) necessitates careful consideration during lactation. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Romcef T 1000mg/125mg Injection can potentially reduce attentiveness, impair vision, and induce drowsiness or dizziness. Operation of a vehicle should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Romcef T 1000mg/125mg Injection use in individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Cefuroxime/sulbactam 1000mg/125mg injection requires careful administration in individuals with significant hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. Altering the dosage of Cefuroxime/sulbactam 1000mg/125mg injection is generally not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Romcef T 1000mg/125mg Injection :
Omit a Romcef T 1000mg/125mg Injection dose? Seek your physician's advice.
Facts to Know About Romcef T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently